214 related articles for article (PubMed ID: 31348934)
1. A Self-Nanoemulsifying Drug Delivery System for Enhancing the Oral Bioavailability of Candesartan Cilexetil: Ex Vivo and In Vivo Evaluation.
AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
J Pharm Sci; 2019 Nov; 108(11):3599-3608. PubMed ID: 31348934
[TBL] [Abstract][Full Text] [Related]
2. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil.
AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
Eur J Pharm Sci; 2017 Nov; 109():503-513. PubMed ID: 28889028
[TBL] [Abstract][Full Text] [Related]
3. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
4. Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets.
Patel J; Dhingani A; Garala K; Raval M; Sheth N
Drug Deliv; 2014 Sep; 21(6):412-35. PubMed ID: 24215334
[TBL] [Abstract][Full Text] [Related]
5. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
6. Design and optimization of candesartan loaded self-nanoemulsifying drug delivery system for improving its dissolution rate and pharmacodynamic potential.
Verma R; Kaushik D
Drug Deliv; 2020 Dec; 27(1):756-771. PubMed ID: 32397771
[TBL] [Abstract][Full Text] [Related]
7. DEVELOPMENT OF SOLID LIPID NANOCARRIERS FOR ORAL DELIVERY OF CANDESERTAN CILEXETIL.
Ugurlu T; Nalbantoglu A; Sengel-Turk CT
Acta Pol Pharm; 2016 Nov; 73(6):1631-1638. PubMed ID: 29634119
[TBL] [Abstract][Full Text] [Related]
8. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A
Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361
[TBL] [Abstract][Full Text] [Related]
9. Self Nanoemulsifying Drug Delivery System of Sorafenib Tosylate: Development and
Sandhya P; Poornima P; Bhikshapathi DVRN
Pharm Nanotechnol; 2020; 8(6):471-484. PubMed ID: 33069205
[TBL] [Abstract][Full Text] [Related]
10. Oral bioavailability and intestinal absorption of candesartan cilexetil: role of naringin as P-glycoprotein inhibitor.
Gurunath S; Nanjwade BK; Patil PA
Drug Dev Ind Pharm; 2015 Jan; 41(1):170-6. PubMed ID: 24168234
[TBL] [Abstract][Full Text] [Related]
11. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and
Amer AM; Allam AN; Abdallah OY
Drug Dev Ind Pharm; 2019 Jul; 45(7):1140-1148. PubMed ID: 30912678
[TBL] [Abstract][Full Text] [Related]
13. Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension treatment.
Usta DY; Timur B; Teksin ZS
Eur J Pharm Sci; 2022 Jul; 174():106159. PubMed ID: 35263632
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of solid oral dosage form incorporating candesartan nanoparticles.
Nekkanti V; Pillai R; Venkateshwarlu V; Harisudhan T
Pharm Dev Technol; 2009; 14(3):290-8. PubMed ID: 19235553
[TBL] [Abstract][Full Text] [Related]
15. Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability.
Dudhipala N; Veerabrahma K
Ther Deliv; 2017 Feb; 8(2):79-88. PubMed ID: 28088883
[TBL] [Abstract][Full Text] [Related]
16. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
[TBL] [Abstract][Full Text] [Related]
17. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation.
Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
Drug Deliv; 2015; 22(4):552-61. PubMed ID: 24512268
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats.
Heshmati N; Cheng X; Eisenbrand G; Fricker G
J Pharm Sci; 2013 Oct; 102(10):3792-9. PubMed ID: 23934779
[TBL] [Abstract][Full Text] [Related]
19. Efavirenz Self-Nano-Emulsifying Drug Delivery System: In Vitro and In Vivo Evaluation.
Kamble RN; Mehta PP; Kumar A
AAPS PharmSciTech; 2016 Oct; 17(5):1240-7. PubMed ID: 26573159
[TBL] [Abstract][Full Text] [Related]
20. Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation.
Surampalli G; Nanjwade BK; Patil PA; Chilla R
Drug Deliv; 2016 Sep; 23(7):2124-2138. PubMed ID: 25080228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
